News & Analysis as of

Machine Learning Data Collection Regulatory Reform

Hogan Lovells

FDA’s evolving regulatory framework for AI use in drug & device clinical trials and research

Hogan Lovells on

U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, M.D., and other senior FDA officials recently published a “Special Communication” in JAMA describing FDA’s concerns with the use of AI in medical product...more

Sheppard Mullin Richter & Hampton LLP

NIST Updates AI RMF as Mandated by the White House Executive Order on AI

We have now reached the 180-day mark since the White House Executive Order (EO) on the Safe, Secure and Trustworthy Development of AI and we are seeing a flurry of mandated actions being completed. See here for a summary of...more

White & Case LLP

What to Expect in U.S. Privacy for 2024

White & Case LLP on

In 2023, the privacy landscape saw a proliferation of comprehensive state data privacy laws being enacted in several jurisdictions, as well as a few that have also taken effect. Although, many of the laws are similar,...more

Akin Gump Strauss Hauer & Feld LLP

President Biden’s AI EO: Key Takeaways for Cybersecurity & Data Privacy

On October 30, 2023, the Biden administration released a far-reaching executive order (EO) on the Safe, Secure, and Trustworthy Development and Use of Artificial Intelligence (AI). The EO issues directives related to the use...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide